Patents by Inventor Dimitrios TRAFALIS

Dimitrios TRAFALIS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10513529
    Abstract: Derivatives of 1,2,4-Triazolo-[3,4-b]-1,3,4-thiadiazoles according to formula (I), as set forth below: processes for production thereof, pharmaceutical compositions containing the same and the use thereof in treatment of cancer.
    Type: Grant
    Filed: July 14, 2017
    Date of Patent: December 24, 2019
    Assignees: GALENICA S.A., ENERGONBIO TECHNOLOGIES S.A.
    Inventor: Dimitrios Trafalis
  • Publication number: 20190194228
    Abstract: Derivatives of 1,2,4-Triazolo-[3,4-b]-1,3,4-thiadiazoles according to formula (I), as set forth below: processes for production thereof, pharmaceutical compositions containing the same and the use thereof in treatment of cancer.
    Type: Application
    Filed: July 14, 2017
    Publication date: June 27, 2019
    Inventor: Dimitrios TRAFALIS
  • Patent number: 10208083
    Abstract: Novel homo-aza-steroidal esters with alkylating bis(2-chloroethyl)aminophenoxy propanoic acid and substituted derivatives, processes for their preparation, pharmaceutical compositions containing them and use thereof in the treatment of cancer.
    Type: Grant
    Filed: June 28, 2016
    Date of Patent: February 19, 2019
    Assignees: Galenica S.A., Energonbio Technologies S.A.
    Inventor: Dimitrios Trafalis
  • Publication number: 20180194800
    Abstract: Novel homo-aza-steroidal esters with alkylating bis(2-chloroethyl)aminophenoxy propanoic acid and substituted derivatives, processes for their preparation, pharmaceutical compositions containing them and use thereof in the treatment of cancer.
    Type: Application
    Filed: June 28, 2016
    Publication date: July 12, 2018
    Inventor: Dimitrios TRAFALIS